Do you want to read an article? Please log in or register.
Severe toxicity-free survival following acute lymphoblastic leukemia in patients aged 1-45 years: a Danish cohort study
Leukemia
Related content
Leukemia
Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Am J Hematol
Ye Y, Labopin M, Yakoub-Agha I, Socié G, Blaise D, Gedde-Dahl T, Blau IW, Raiola AM, Byrne J, Daguindau E, Labussière-Wallet H, Huynh A, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Shi J, Mohty M, Huang H, Ciceri F
doi: 10.1002/ajh.70008
Lung, Respiratory and Thoracic Cancer
Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic Non-small Cell Lung Cancer Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1
J Thorac Oncol
Peters S, Regan MM, Paz-Ares LG, Reck M, Borghaei H, O'Byrne KJ, Brahmer JR, Penrod JR, Li J, Tracy L, Yuan Y, Bushong J, Lee A, Eccles LJ, Ray S, Ramalingam SS
doi: 10.1016/j.jtho.2025.05.019
Leukemia
Prognostic factors and survival outcomes of first CNS relapse in childhood acute lymphoblastic leukemia: results from the ALL-IC REL 2016 study
Leuk Lymphoma
Hazar V, Makiya M, Yalçın K, Cadiu JT, Manni F, Reyes Barragan A, Polychronopoulou S, Colita A, Avramova B, Kavcic M, Ampatzidou M, Radu LE, Hristova T, Prelog T, Höbör B, Farah R, Jazbec J, Erdelyi DJ
doi: 10.1080/10428194.2025.2598861
Leukemia
Outcome of allogeneic hematopoietic cell transplantation in adult acute lymphoblastic leukemia patients who underwent myeloablative TBI-free conditioning regimen
Leuk Lymphoma
Amiri D, Mirzaei M, Bahri T, Barkhordar M, Nejati N, Babakhani D, Biglari M, Yaghmaie M, Rad S, Vaezi M, Alimoghadam K, Janbabai G, Mousavi SA, Fumani HK, Shirjani ST, Ghavamzadeh A
doi: 10.1080/10428194.2025.2548968
Head and Neck Cancer
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study
Lancet Oncol
Cao C, Sherman EJ, Riaz N, McBride SM, Yu Y, Shamseddine A, Wong W, Dunn LA, Ho AL, Wong RJ, Lee NY
doi: 10.1016/S1470-2045(25)00649-7
RECOMMENDED
Breast Cancer
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study
★ 1
Recommended by
Dr Andreas Müller, Faculty Member
J Clin Oncol
Valenza C, Zheng Y, Milano M, Trapani D, Giordano E, Guidi L, Berton Giachetti PPM, Boldrini L, Castellano G, Katrini J, Malagutti B, Antonarelli G, Conforti F, Pagan E, Bagnardi V, Kirkner GJ, Sangalli C, Dibble KE, Colleoni M, Regan MM, Munzone E, Curigliano G, Partridge AH
doi: 10.1200/JCO-25-01660
Leukemia
Five-year molecular response and overall survival with first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: a prospective, observational study - SIMPLICITY
Leuk Lymphoma
Mauro MJ, Hehlmann R, Williams LA, Goldberg SL, Michallet M, Gambacorti-Passerini C, Tang D, DeGutis IS, McBride A, Parsons L, Montelongo M, Cortes JE
doi: 10.1080/10428194.2025.2495369
Gastrointestinal Cancer
Survival benefit of adjuvant chemotherapy in elderly patients with UICC stage III colon carcinoma: A 20-year population-based German cohort study
Eur J Cancer
Langheinrich M, Gerken M, Robers G, Hansinger J, Franke B, Lacruz ME, Mueller-Nordhorn J, Schneider C, Reinwald F, Stang A, Sackmann A, Zeissig SR, Klinkhammer-Schalke M, Kersting S, Völkel V, Benz S
doi: 10.1016/j.ejca.2025.115583
Leukemia
Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Am J Hematol
Ru Y, Chen J, Ferhat AT, Labussière-Wallet H, Gedde-Dahl T, Kröger N, Socié G, Yakoub-Agha I, Eder M, Mielke S, Wu D, Mohty M, Ciceri F, Gorin NC
doi: 10.1002/ajh.70069